Nyxoah Annonce l’Implantation du Premier Patient dans BREATHE, l’Étude Post-Approbation Américaine du Système Genio®

Nyxoah announced the first patient implantation in BREATHE, a post-approval U.S. study of its Genio® system for obstructive sleep apnea treatment. The study will implant up to 229 patients across 25 U.S. centers over five years to evaluate long-term safety and efficacy in real-world clinical practice. The first procedure was performed by Dr. Rolando Molina at South Florida ENT Associates.